213 Immunostimulatory sequence oligodeoxynucleotide induces an innate type 1 cytokine response from human PBMCs and inhibits IL-4 dependent CD23 expression and IgE production

2000 ◽  
Vol 105 (1) ◽  
pp. S69 ◽  
Author(s):  
A HORNER
2011 ◽  
Vol 31 (4) ◽  
pp. 393-400 ◽  
Author(s):  
Adam J. Karpala ◽  
John Bingham ◽  
Karel A. Schat ◽  
Li-Mei Chen ◽  
Ruben O. Donis ◽  
...  

2002 ◽  
Vol 76 (19) ◽  
pp. 9657-9663 ◽  
Author(s):  
Palanivel Velupillai ◽  
John P. Carroll ◽  
Thomas L. Benjamin

ABSTRACT Mice of the PERA/Ei strain (PE mice) are highly susceptible to tumor induction by polyomavirus and transmit their susceptibility in a dominant manner in crosses with resistant C57BR/cdJ mice (BR mice). BR mice respond to polyomavirus infection with a type 1 cytokine response and develop effective cell-mediated immunity to the virus-induced tumors. By enumerating virus-specific CD8+ T cells and measuring cytokine responses, we show that the susceptibility of PE mice is due to the absence of a type 1 cytokine response and a concomitant failure to sustain virus-specific cytotoxic T lymphocytes. (PE × BR)F1 mice showed an initial type 1 response that became skewed toward type 2. Culture supernatants of splenocytes from infected PE mice stimulated in vitro contained high levels of interleukin-10 and no detectable gamma interferon, while those from BR mice showed the opposite pattern. Differences in the innate immune response to polyomavirus by antigen-presenting cells in PE mice and BR mice led to polarization of T-cell cytokine responses. Adherent cells from spleens of infected BR mice produced high levels of interleukin-12, while those from infected PE and F1 mice produced predominantly interleukin-10. PE and F1 mice infected by polyomavirus responded with increases in antigen-presenting cells expressing B7.2 costimulatory molecules, whereas BR mice responded with increased expression of B7.1. Administration of recombinant interleukin-12 along with virus resulted in partial protection of PE mice and provided complete protection against tumor development in F1 animals.


2011 ◽  
Vol 33 (9) ◽  
pp. 495-505 ◽  
Author(s):  
J. PLEASANCE ◽  
E. WIEDOSARI ◽  
H. W. RAADSMA ◽  
E. MEEUSEN ◽  
D. PIEDRAFITA

1997 ◽  
Vol 73 (5) ◽  
pp. 387-390
Author(s):  
G Stellato ◽  
P Nieminen ◽  
M Aho ◽  
T Lehtinen ◽  
M Lehtinen ◽  
...  

1997 ◽  
Vol 56 ◽  
pp. 304
Author(s):  
V.E.C.J. Schijns ◽  
C.M.H. Wierda ◽  
B. Haagmans ◽  
I. Heijnen ◽  
G. Alber ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document